BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15213710)

  • 1. Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it?
    Verburg FA; Lips CJ; Lentjes EG; de Klerk JM
    Br J Cancer; 2004 Jul; 91(2):200-4. PubMed ID: 15213710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
    Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
    Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
    Denizot A; Delfino C; Dutour-Meyer A; Fina F; Ouafik L
    Thyroid; 2003 Sep; 13(9):867-72. PubMed ID: 14588101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer.
    Grammatopoulos D; Elliott Y; Smith SC; Brown I; Grieve RJ; Hillhouse EW; Levine MA; Ringel MD
    Mol Pathol; 2003 Jun; 56(3):162-6. PubMed ID: 12782763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
    Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
    Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid cancer patients.
    Savagner F; Rodien P; Reynier P; Rohmer V; Bigorgne JC; Malthiery Y
    J Clin Endocrinol Metab; 2002 Feb; 87(2):635-9. PubMed ID: 11836297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
    Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
    Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
    Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood.
    Biscolla RP; Cerutti JM; Maciel RM
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3623-7. PubMed ID: 11061512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancer.
    Eszlinger M; Neumann S; Otto L; Paschke R
    Eur J Endocrinol; 2002 Nov; 147(5):575-82. PubMed ID: 12444888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin.
    Westbury C; Vini L; Fisher C; Harmer C
    Thyroid; 2000 Feb; 10(2):171-6. PubMed ID: 10718555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human thyrotropin stimulation of thyroglobulin in the follow-up of patients with stage I or II differentiated thyroid carcinoma.
    Baskin HJ; Atwood TM; Holcomb LP
    Endocr Pract; 2000; 6(6):430-4. PubMed ID: 11155213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland.
    Petric R; Besic H; Besic N
    World J Surg Oncol; 2014 Sep; 12():282. PubMed ID: 25213012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients.
    Vendittelli F; Raffaelli M; Fadda G; Carelli-Alinovi C; Paolillo C; Bellantone R; Zuppi C; Capoluongo E
    Clin Chem Lab Med; 2012 Jan; 50(4):715-20. PubMed ID: 22505562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum oncofetal fibronectin (onfFN) mRNA in differentiated thyroid carcinoma (DTC): large overlap between disease-free and metastatic patients.
    Sritara C; Charoenphun P; Ponglikitmongkol M; Musikarat S; Utamakul C; Chokesuwattanasakul P; Thakkinstian A
    Asian Pac J Cancer Prev; 2012; 13(8):4203-8. PubMed ID: 23098431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects.
    Li D; Butt A; Clarke S; Swaminathana R
    Ann N Y Acad Sci; 2004 Jun; 1022():147-51. PubMed ID: 15251954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroglobulin mRNA amplification in peripheral blood of patients with differentiated thyroid carcinoma: what does it really mean?].
    Coelho SM; Vaisman M; de Carvalho DP
    Arq Bras Endocrinol Metabol; 2006 Jun; 50(3):427-35. PubMed ID: 16936982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours.
    Hocevar M; Auersperg M
    Eur J Surg Oncol; 1998 Dec; 24(6):553-7. PubMed ID: 9870733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
    Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
    Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.